Cargando…
A Novel Anti-CD44 Variant 9 Monoclonal Antibody C(44)Mab-1 Was Developed for Immunohistochemical Analyses against Colorectal Cancers
Cluster of differentiation 44 (CD44) is a type I transmembrane glycoprotein and has been shown to be a cell surface marker of cancer stem-like cells in various cancers. In particular, the splicing variants of CD44 (CD44v) are overexpressed in cancers and play critical roles in cancer stemness, invas...
Autores principales: | Tawara, Mayuki, Suzuki, Hiroyuki, Goto, Nohara, Tanaka, Tomohiro, Kaneko, Mika K., Kato, Yukinari |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10137259/ https://www.ncbi.nlm.nih.gov/pubmed/37185762 http://dx.doi.org/10.3390/cimb45040238 |
Ejemplares similares
-
Development of a Novel Anti-CD44 Variant 4 Monoclonal Antibody C(44)Mab-108 for Immunohistochemistry
por: Suzuki, Hiroyuki, et al.
Publicado: (2023) -
Development of a Novel Anti-CD44 Variant 8 Monoclonal Antibody C(44)Mab-94 against Gastric Carcinomas
por: Suzuki, Hiroyuki, et al.
Publicado: (2023) -
A Novel Anti-CD44 Variant 3 Monoclonal Antibody C(44)Mab-6 Was Established for Multiple Applications
por: Suzuki, Hiroyuki, et al.
Publicado: (2023) -
Development of a Novel Anti-CD44 Variant 6 Monoclonal Antibody C(44)Mab-9 for Multiple Applications against Colorectal Carcinomas
por: Ejima, Ryo, et al.
Publicado: (2023) -
Development of a Novel Anti-CD44 Variant 5 Monoclonal Antibody C(44)Mab-3 for Multiple Applications against Pancreatic Carcinomas
por: Kudo, Yuma, et al.
Publicado: (2023)